In vitro growth rates of cells harboring resistance mutations [8].
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
The table displays the type of resistance mutation (ordered in terms of decreasing growth rate), net growth rate (mean and standard error), and sensitivity to the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib. p210 refers to the drug-sensitive BCR-ABL-positive cell type.
创建时间：
2011-11-28
